Detalles de la búsqueda
1.
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.
Lancet Oncol
; 17(2): 212-223, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26727163
2.
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
Eur J Cancer
; 191: 112981, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37506588
3.
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.
Lancet Oncol
; 12(12): 1125-33, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22019520
Resultados
1 -
3
de 3
1
Próxima >
>>